This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Chen PR , Balachandran S
Development of interferon gamma-based immunocytokines targeting renal cancer
Oncoimmunology. 2013 Jul;2(7) :e24964
PMID: WOS:000324588300004 PMCID: PMC 3782162
AbstractAdvanced renal cancer is an incurable malignancy in need of novel therapeutic avenues. We have generated interferon (IFN)-based fusion antibodies (immunocytokines) that target CD70, a putative biomarker of renal cancer. These immunocytokines efficiently labeled renal cancer cells, and, when combined with the proteasome inhibitor bortezomib, killed them by activating a RIP1-dependent necrotic pathway.
NotesChen, Peirong Balachandran, Siddharth